Weed (BUDZ) Cash & Current Investments (2017 - 2026)
Weed's (BUDZ) quarterly Cash & Current Investments came in at $1795.0 in Q1 2026, down 42.87% year-on-year from $3142.0 in Q1 2025, and down 94.58% quarter-over-quarter from $33130.0 in Q4 2025.
Weed (BUDZ) Cash & Current Investments (2017 - 2026) Analysis & Trends
Weed's Cash & Current Investments history runs 10 years deep, the most recent figure standing at $1795.0 for Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 42.87% year-over-year to $1795.0 in Q1 2026; TTM through Mar 2026 was $1795.0, a 42.87% decrease from a year earlier, with the FY2025 full-year figure at $33130.0, down 79.21% from the prior year.
- Cash & Current Investments eased to $1795.0 in Q1 2026 per BUDZ's latest filing, from $33130.0 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $821094.0 in Q2 2022 and bottomed at $400.0 in Q3 2025.
- The 5-year median for Cash & Current Investments is $33888.0 (2022), against an average of $182152.4.
- Across the five-year window, Cash & Current Investments surged 1506.93% in 2022 and sank 99.17% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $315826.0 in 2022, then dropped by 8.05% to $290409.0 in 2023, then slumped by 45.13% to $159355.0 in 2024, then sank by 79.21% to $33130.0 in 2025, then sank by 94.58% to $1795.0 in 2026.
- Per Business Quant, the three latest BUDZ Cash & Current Investments figures stand at $1795.0 (Q1 2026), $33130.0 (Q4 2025), and $400.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Weed | 2.77 Mn | 2.77 Mn | - | 1,795.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,795.00 |
| Dec 31, 2025 | 33,130.00 |
| Sep 30, 2025 | 400.00 |
| Jun 30, 2025 | 5,350.00 |
| Mar 31, 2025 | 3,142.00 |
| Dec 31, 2024 | 159,355.00 |
| Sep 30, 2024 | 5,311.00 |
| Jun 30, 2024 | 16,745.00 |
| Mar 31, 2024 | 102,696.00 |
| Dec 31, 2023 | 290,409.00 |
| Sep 30, 2023 | 643,702.00 |
| Jun 30, 2023 | 32,469.00 |
| Mar 31, 2023 | 95,751.00 |
| Dec 31, 2022 | 315,826.00 |
| Sep 30, 2022 | 535,527.00 |
| Jun 30, 2022 | 821,094.00 |
| Mar 31, 2022 | 33,888.00 |
| Dec 31, 2021 | 19,654.00 |
| Sep 30, 2021 | 303,739.00 |
| Jun 30, 2021 | 260,602.00 |